EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors

Kothmaier, H; Quehenberger, F; Halbwedl, I; Morbini, P; Demirag, F; Zeren, H; Comin, C E; Murer, B; Cagle, P T; Attanoos, R; Gibbs, A A; Galateau-Salle, F; Popper, H H
April 2008
Thorax;Apr2008, Vol. 63 Issue 4, p345
Academic Journal
Background: Malignant pleural mesothelioma (MPM) is an asbestos related tumour difficult to detect early and treat effectively. Asbestos causes genetic modifications and cell signalling events that favour the resistance of MPM to apoptosis and chemotherapy. Only a small number of patients, approximately 10%, survive more than 3 years. The aim of our study was to assess possible differences within signalling pathways between short term survivors (survival <3 years; STS) and long term survivors (survival >3 years; LTS) of MPM. Methods: 37 antibodies detecting proteins engaged in cell signalling pathways, enforcing proliferation, antiapoptosis, angiogenesis and other cellular activities were investigated by tissue microarray (TMA) technology. Results: Epidermal growth factor receptor (EGFR) was expressed stronger in LTS whereas platelet derived growth factor receptor (PDGFR) signalling was more abundant in STS. Expression of TIE2/Tek, a receptor for tyrosine kinases involved in angiogenesis, was differentially regulated via PDGFR and thus is more important in STS. Antiapoptosis was upregulated in STS by signal transducer and activator of transcription 1 (STAT1)—survivin and related molecules, but not in LTS. Our study provides novel insights into the regulatory mechanisms of signalling pathways in MPM, which differentially promote tumour growth in LTS and STS. Conclusion: We have demonstrated that small scale proteomics can be carried out by powerful linkage of TMA, immunohistochemistry and statistical methods to identify proteins which might be relevant targets for therapeutic intervention.


Related Articles

  • Epithelial Inflammation Resulting from an Inherited Loss-of-Function Mutation in EGFR. Campbell, Patrick; Morton, Penny E; Takeichi, Takuya; Salam, Amr; Roberts, Nerys; Proudfoot, Laura E; Mellerio, Jemima E; Aminu, Kingi; Wellington, Cheryl; Patil, Sachin N; Akiyama, Masashi; Liu, Lu; McMillan, James R; Aristodemou, Sophia; Ishida-Yamamoto, Akemi; Abdul-Wahab, Alya; Petrof, Gabriela; Fong, Kenneth; Harnchoowong, Sarawin; Stone, Kristina L // Journal of Investigative Dermatology;Oct2014, Vol. 134 Issue 10, p2570 

    Epidermal growth factor receptor (EGFR) signaling is fundamentally important for tissue homeostasis through EGFR/ligand interactions that stimulate numerous signal transduction pathways. Aberrant EGFR signaling has been reported in inflammatory and malignant diseases, but thus far no primary...

  • Catching up to the speed of signaling. de Souza, Natalie // Nature Methods;Jun2007, Vol. 4 Issue 6, p476 

    A simple, continuous quench-flow system allows quantitative analysis of very early cellular signaling events.

  • Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. Wandinger, Sebastian K.; Lahortiga, Idoya; Jacobs, Kris; Klammer, Martin; Jordan, Nicole; Elschenbroich, Sarah; Parade, Marc; Jacoby, Edgar; Linders, Joannes T. M.; Brehmer, Dirk; Cools, Jan; Daub, Henrik // PLoS ONE;1/8/2016, Vol. 11 Issue 1, p1 

    The four members of the epidermal growth factor receptor (EGFR/ERBB) family form homo- and heterodimers which mediate ligand-specific regulation of many key cellular processes in normal and cancer tissues. While signaling through the EGFR has been extensively studied on the molecular level,...

  • Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma. Mezzapelle, R; Miglio, U; Rena, O; Paganotti, A; Allegrini, S; Antona, J; Molinari, F; Frattini, M; Monga, G; Alabiso, O; Boldorini, R // British Journal of Cancer;4/30/2013, Vol. 108 Issue 8, p1743 

    Background:As epidermal growth factor receptor (EGFR) is involved in the pathogenesis of malignant pleural mesotheliomas (MPMs), the anti-EGFR drugs may be effective in treating MPM patients. Mutations of the EGFR gene or its downstream effectors may cause constitutive activation leading to cell...

  • Epidermal growth factor: the driving force in initiation of RPE cell proliferation. Steindl-Kuscher, Kerstin; Boulton, Michael; Haas, Paulina; Dossenbach-Glaninger, Astrid; Feichtinger, Hans; Binder, Susanne // Graefe's Archive of Clinical & Experimental Ophthalmology;Aug2011, Vol. 249 Issue 8, p1195 

    Background: To analyze whether epidermal growth factor (EGF) exerts regulatory effects on proliferation and differentiation in ARPE19 cells after different incubation periods (24 vs. 48 h) for obtaining ideal conditions for feasible rejuvenation and autologous transplantation of retinal pigment...

  • Identification of tyrosine phosphoproteins in signaling pathway triggered TGF-a by using functional proteomics technology. Ruan, Lin; Wang, Guo-Liang; Chen, Yan; Yi, Hong; Tang, Can-E; Zhang, Peng-Fei; Li, Mao-Yu; Li, Cui; Peng, Fang; Li, Jian-Ling; Chen, Zhu-Chu; Xiao, Zhi-Qiang // Medical Oncology;Dec2010, Vol. 27 Issue 4, p1407 

    lthough several groups had conducted proteomics of nasopharyngeal carcinoma (NPC), little study was involved in phosphoproteomics, oncogenic signaling, and cancer research about NPC. Analysis of phosphotyrosine proteins from transforming growth factor alpha (TGF-a) triggered phosphotyrosine...

  • CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-γ and Hsp70/Hsc70. Doong, Howard; Price, John; Kim, Young Sook; Gasbarre, Christopher; Probst, Julie; Liotta, Lance A; Blanchette, Jay; Rizzo, Kathryn; Kohn, Elise // Oncogene;9/7/2000, Vol. 19 Issue 38, p4385 

    CAIR-1/BAG-3 forms an EGF-regulated ternary complex with Hsp70/Hsc70 and latent phospholipase C-γ (PLC-γ). The expression of CAIR-1, CAI stressed-1, was induced in A2058 human melanoma cells by continuous exposure to CAI, an inhibitor of nonvoltage-gated calcium influx. CAIR-1 sequence is...

  • The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Lanzetti, Letizia; Rybin, Vladimir; Malabarba, Maria Grazia; Christoforidis, Savvas; Scita, Giorgio; Zerial, Marino; Di Fiore, Pier Paolo // Nature;11/16/2000, Vol. 408 Issue 6810, p374 

    Reports that the protein Eps8, a substrate of the epidermal growth factor receptor (EGFR) connects the signalling pathways involving small GTPases of the Rho and Rab families, thereby mediating activation of Rac. Study which shows that RN-tre, with which Eps8 interacts, is a Rab5...

  • Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor. Tang, Jiping; Feng, Gen-Sheng; Li, Wei // Oncogene;10/9/97, Vol. 15 Issue 15, p1823 

    The SH3-SH3-SH3-SH2 adapter protein Nck links receptor tyrosine kinases, such as EGF and PDGF receptors, to downstream signaling pathways, among which p21cdc42/rac-activated kinase cascade, Sos-activated Ras signaling and the human Wiskott-Aldrich Syndrome protein (WASp)-mediated actin...


Read the Article


Sign out of this library

Other Topics